NeuroXess

Active#14 worldwide · Connected devicesNot open to Backers

Estimated valuation · Connected devices · China

Develops invasive brain-computer interface systems using flexible high-density electrodes for speech decoding and motor restoration in patients with paralysis and neurological disorders.

Healthtech›Connected devices neuroxess.com

HQChina

Last roundSeries B · Oct 2026

Estimated valuation

AI · Connected devices ranking (worldwide)

≈ USD 510MUSD 250M–1bn · Hundreds of M$

Hundreds of k$

Millions $

Tens of M$

Hundreds of M$

Unicorn

Decacorn

Hectocorn

Anchor: Last known equity round: Series B · USD 98.6M · Oct 2026

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
Connected devices · worldwide	Top 30	#14	Edition 0 · Oct 2026	25 Mar 2027

Rank historyOct 2026 · #14 Connected devicesFirst edition: no movements yet.

Funding history

Date	Round	Amount	Type	Investors
Oct 2026	Series B	USD 98.6M	Equity	SDIC Juli, Shenzhen Capital Group, Qinzhi Capital

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of NeuroXess as a PDF. It must answer at least one of these four questions, and stick to them:

AI valuation: $510MUndervalued or overvalued?

Versus competitorsHow does it compare?

Who should acquire itStrategic buyers, and why

Who should it acquireAcquisition targets, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Invest

Not open to BackersCompanies based in mainland China are ranked like any other startup, but Uback does not open pools on them: capital controls and offshore (VIE) structures make minority deals impractical for our Backers.

You can still declare an interest in this segment:

Or back connected devices worldwide

Do you run NeuroXess?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round.

Claim this profile Report an upcoming round → Report an error →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Read by the AI at the next edition.

Comparable companies in connected devices

Full connected devices ranking →

Biolinq#13United StatesHundreds of M$Cala Health#15United StatesHundreds of M$Neuracle#12ChinaHundreds of M$StairMed#16ChinaHundreds of M$

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.